Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 29, 2015 6:24 PM ET

Healthcare Equipment and Supplies

Company Overview of Bausch & Lomb Incorporated

Company Overview

Bausch & Lomb Incorporated develops, manufactures, and markets eye care products. It focuses on protecting, enhancing, and restoring people’s eyesight. The company offers contact and hydrophobic acrylic intraocular lenses; contact lens care, dry eye, allergy/redness relief, Rx pharmaceutical, and surgical products; and eye vitamins, vision accessories, and safety and industrial cleaning products. It also offers contract manufacturing services for sterile and non-sterile solutions, suspensions, ointments, gels, creams, nasals, and injectables. The company was formerly known as Bausch & Lomb Optical Company and changed its name to Bausch & Lomb Incorporated in March 1960. The company was found...

1400 North Goodman Street

Rochester, NY 14609

United States

Founded in 1853

13,000 Employees





Key Executives for Bausch & Lomb Incorporated

President of Asia-Pacific
Age: 70
Corporate Vice President and President of Latin America Operations
Chief Medical Officer and Executive Vice President
Age: 63
Head of Sales for US Vision Care Division
Head of U.S. Eye Health
Age: 52
Compensation as of Fiscal Year 2015.

Bausch & Lomb Incorporated Key Developments

Bausch + Lomb Confirms Submission of Vesneo(TM) NDA to US FDA

Nicox S.A. announced that Valeant Pharmaceuticals International, Inc's. wholly owned subsidiary, Bausch + Lomb has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for VESNEO(TM) (latanoprostene bunod ophthalmic solution 0.024%), an IOP lowering single-agent eye drop dosed once daily, for patients with open angle glaucoma or ocular hypertension. The data submitted in the NDA support VESNEO as the first nitric-oxide donating agent for ophthalmic use.

Bausch + LombExpands its Ocuvite Line of Eye Vitamin and Mineral Supplements with Launch of Ocuvite Eye Health Gummies for Adults

Bausch + Lomb expanded its Ocuvite line of eye vitamin and mineral supplements with the launch of Ocuvite Eye Health Gummies for adults. New Ocuvite Eye Health Gummies are formulated to help replenish vital nutrients eyes can lose with age and are a great tasting way to help protect eye health. The unique Vitamins C and E and zinc at levels that provide the recommended daily intake and macular carotenoids lutein and zeaxanthin at levels identified by ocular nutrition experts to support eye health.

Bausch + Lomb Announces the Availability of TRULIGN Toric Intraocular Lens

Bausch + Lomb has announced the availability of TRULIGN Toric intraocular lens, or IOL, with power range of 10.0-16.5, or in half diopter steps. The TRULIGN Toric intraocular lens is the first and only toric IOL in the US that corrects for astigmatism and has the additional capacity to deliver improved vision across a natural range of focus. When using a standard toric IOL, patients typically can only have focus for distance vision, however, with the aberration-free advanced optics featured in TRULIGN, patients are provided excellent visual acuity at intermediate and distance (UCIVA/UCDVA greater than or equal to 20/40: 97.8% of eyes). Additionally, 99.2% of study participants who received the TRULIGN Toric IOL reported no visual disturbances on postoperative refraction following cataract surgery. The innovative TRULIGN Toric's advanced aspheric optics provides excellent acuity andcontrast for driving at night, minimizing halos and glare, as well as offering a uniform power, center to edge, for predictable results. Bausch + Lomb's TRULIGN Toric also offers outstanding rotational stability (rotation less than or equal to 5o: 96.1% of eyes) and effective cylinder correction (residual cylinder less than or equal to 1.0 D: 95.5% of eyes).

Similar Private Companies By Industry

Company Name Region
Upex, LLC United States
CardioMag Imaging, Inc. United States
Beckman Coulter, Inc. United States
Pintler Medical, LLC United States
Visual Performance Diagnostics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bausch & Lomb Incorporated, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at